94 related articles for article (PubMed ID: 23060559)
1. Tissue distribution of (Lipocurc™) liposomal curcumin and tetrahydrocurcumin following two- and eight-hour infusions in Beagle dogs.
Matabudul D; Pucaj K; Bolger G; Vcelar B; Majeed M; Helson L
Anticancer Res; 2012 Oct; 32(10):4359-64. PubMed ID: 23060559
[TBL] [Abstract][Full Text] [Related]
2. Infusion pharmacokinetics of Lipocurc™ (liposomal curcumin) and its metabolite tetrahydrocurcumin in Beagle dogs.
Helson L; Bolger G; Majeed M; Vcelar B; Pucaj K; Matabudul D
Anticancer Res; 2012 Oct; 32(10):4365-70. PubMed ID: 23060560
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals.
Bolger GT; Licollari A; Tan A; Greil R; Vcelar B; Greil-Ressler S; Weiss L; Schönlieb C; Magnes T; Radl B; Majeed M; Sordillo PP
Cancer Chemother Pharmacol; 2019 Feb; 83(2):265-275. PubMed ID: 30430227
[TBL] [Abstract][Full Text] [Related]
4. Distribution and Metabolism of Lipocurc™ (Liposomal Curcumin) in Dog and Human Blood Cells: Species Selectivity and Pharmacokinetic Relevance.
Bolger GT; Licollari A; Tan A; Greil R; Vcelar B; Majeed M; Helson L
Anticancer Res; 2017 Jul; 37(7):3483-3492. PubMed ID: 28668837
[TBL] [Abstract][Full Text] [Related]
5. Distribution of Curcumin and THC in Peripheral Blood Mononuclear Cells Isolated from Healthy Individuals and Patients with Chronic Lymphocytic Leukemia.
Bolger GT; Licollari A; Tan A; Greil R; Pleyer L; Vcelar B; Majeed M; Sordillo P
Anticancer Res; 2018 Jan; 38(1):121-130. PubMed ID: 29277764
[No Abstract] [Full Text] [Related]
6. Biotransformation of curcumin through reduction and glucuronidation in mice.
Pan MH; Huang TM; Lin JK
Drug Metab Dispos; 1999 Apr; 27(4):486-94. PubMed ID: 10101144
[TBL] [Abstract][Full Text] [Related]
7. Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans.
Storka A; Vcelar B; Klickovic U; Gouya G; Weisshaar S; Aschauer S; Bolger G; Helson L; Wolzt M
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):54-65. PubMed ID: 25500488
[TBL] [Abstract][Full Text] [Related]
8. Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chronic Lymphocytic Leukemia Cells.
Bolger GT; Licollari A; Bagshaw R; Tan A; Greil R; Vcelar B; Majeed M; Sordillo P
Anticancer Res; 2019 Mar; 39(3):1161-1168. PubMed ID: 30842145
[TBL] [Abstract][Full Text] [Related]
9. Influence of tetrahydrocurcumin on erythrocyte membrane bound enzymes and antioxidant status in experimental type 2 diabetic rats.
Murugan P; Pari L
J Ethnopharmacol; 2007 Sep; 113(3):479-86. PubMed ID: 17693046
[TBL] [Abstract][Full Text] [Related]
10. [Tissue levels of pirarubicin (THP) in dogs following intra-arterial infusion].
Sumiyoshi Y; Yokota K; Akiyama M; Kawaoto H; Kosugi I
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1621-6. PubMed ID: 1872619
[TBL] [Abstract][Full Text] [Related]
11. Tetrahydrocurcumin inhibits HT1080 cell migration and invasion via downregulation of MMPs and uPA.
Yodkeeree S; Garbisa S; Limtrakul P
Acta Pharmacol Sin; 2008 Jul; 29(7):853-60. PubMed ID: 18565284
[TBL] [Abstract][Full Text] [Related]
12. Validation of Large White Pig as an animal model for the study of cannabinoids metabolism: application to the study of THC distribution in tissues.
Brunet B; Doucet C; Venisse N; Hauet T; Hébrard W; Papet Y; Mauco G; Mura P
Forensic Sci Int; 2006 Sep; 161(2-3):169-74. PubMed ID: 16859848
[TBL] [Abstract][Full Text] [Related]
13. Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats.
Pari L; Murugan P
Ren Fail; 2007; 29(7):881-9. PubMed ID: 17994458
[TBL] [Abstract][Full Text] [Related]
14. Carboxymethylcellulose-tetrahydrocurcumin conjugates for colon-specific delivery of a novel anti-cancer agent, 4-amino tetrahydrocurcumin.
Plyduang T; Lomlim L; Yuenyongsawad S; Wiwattanapatapee R
Eur J Pharm Biopharm; 2014 Oct; 88(2):351-60. PubMed ID: 24859389
[TBL] [Abstract][Full Text] [Related]
15. Antihyperlipidemic effect of chlorogenic acid and tetrahydrocurcumin in rats subjected to diabetogenic agents.
Karthikesan K; Pari L; Menon VP
Chem Biol Interact; 2010 Dec; 188(3):643-50. PubMed ID: 20696151
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats.
Murugan P; Pari L
Life Sci; 2006 Sep; 79(18):1720-8. PubMed ID: 16806281
[TBL] [Abstract][Full Text] [Related]
17. Influence of tetrahydrocurcumin on hepatic and renal functional markers and protein levels in experimental type 2 diabetic rats.
Murugan P; Pari L
Basic Clin Pharmacol Toxicol; 2007 Oct; 101(4):241-5. PubMed ID: 17845505
[TBL] [Abstract][Full Text] [Related]
18. Liposome distribution after intravenous and selective intraarterial infusion in dogs.
Wright KC; Kasi LP; Jahns MS; Hashimoto S; Wallace S
Radiology; 1990 Sep; 176(3):691-4. PubMed ID: 2389028
[TBL] [Abstract][Full Text] [Related]
19. Comparative radical-scavenging activity of curcumin and tetrahydrocurcumin with thiols as measured by the induction period method.
Kadoma Y; Fujisawa S
In Vivo; 2007; 21(6):979-82. PubMed ID: 18210744
[TBL] [Abstract][Full Text] [Related]
20. Influence of tetrahydrocurcumin on tail tendon collagen contents and its properties in rats with streptozotocin-nicotinamide-induced type 2 diabetes.
Pari L; Murugan P
Fundam Clin Pharmacol; 2007 Dec; 21(6):665-71. PubMed ID: 18034669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
